(Q54016939)

English

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

de Haas V

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Verhagen OJ

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

von dem Borne AE

3

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Kroes W

4

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

van den Berg H

5

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

van der Schoot CE

6

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

15

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

134-140

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of lymphoblasts in cerebrospinal fluid in newly diagnosed pediatric acute lymphoblastic malignancies with bone marrow involvement: possible benefit of dexamethasone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning of human immunoglobulin mu gene and comparison with mouse mu gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Complex rearrangements within the human J delta-C delta/J alpha-C alpha locus and aberrant recombination between J alpha segments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Computer aided design and evaluation of limiting and serial dilution experiments.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401970

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2401970

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11243381

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54016939&oldid=2212345860"